UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - APPLIED THERAPEUTICS INC ownership

APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 73 filers reported holding APPLIED THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of APPLIED THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$47,886,000
-76.4%
22,6950.0%0.00%
Q4 2021$203,119,000
-46.1%
22,6950.0%0.00%
Q3 2021$376,737,000
-20.1%
22,6950.0%0.00%
Q2 2021$471,602,000
+115.0%
22,695
+274.1%
0.00%
Q2 2020$219,322,0006,0670.00%
Other shareholders
APPLIED THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Propel Bio Management, LLC 6,567,858$30,671,89719.89%
Knoll Capital Management, LLC 5,574,687$26,033,78817.54%
STEMPOINT CAPITAL LP 2,211,320$10,326,8643.04%
VR Adviser, LLC 9,542,871$44,565,2082.84%
Vestal Point Capital, LP 5,430,000$25,358,1001.89%
Opaleye Management Inc. 1,680,000$7,845,6001.79%
TANG CAPITAL MANAGEMENT LLC 2,330,000$10,881,1001.11%
Perceptive Advisors 8,005,000$37,383,3500.90%
Simplify Asset Management Inc. 2,817,505$13,157,7480.88%
Parkman Healthcare Partners LLC 1,148,307$5,362,5940.72%
View complete list of APPLIED THERAPEUTICS INC shareholders